Switch from perforin-expressing to perforin-deficient CD8+ T cells accounts for two distinct types of effector cytotoxic T lymphocytes in vivo

Immunology

Volumn 128, Issue 1, 2009, Pages 69-82

  Meiraz, Avihai ^a   Garber, Orit Gal ^a   Harari, Shaul ^a   Hassin, David ^b   Berke, Gideon ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Allograft rejection; CD8 T cells; Cytotoxic T lymphocyte; Fas; Fas ligand; Perforin

Indexed keywords

FAS ANTIGEN; FAS LIGAND; PERFORIN;

ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL KILLING; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; GRAFT REJECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; GRAFT REJECTION; IMMUNOLOGIC MEMORY; LEUKEMIA, EXPERIMENTAL; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; PERFORIN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 68249084830     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03072.x     Document Type: Article

References (58)

1. Cerottini JC, Brunner KT. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol 1974 18 : 67 132.
2. Kägi D, Ledermann B, Burki K, Zinkernagel RM, Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol 1996 14 : 207 32.
3. Trapani JA, Smyth MJ. Functional significance of the perforin\granzyme cell death pathway. Nat Rev Immunol 2002 2 : 735 47.
4. + effector cells. Adv Immunol 2004 83 : 233 52.
5. Berke G, Clark W. Killer lymphocytes. Berlin : Springer, 2005.
6. Williams MA, Bevan MJ. Effector and memory CTL differentiation. Annu Rev Immunol 2007 25 : 171 92.
7. + T cells by perforin. Eur J Immunol 1999 29 : 3262 72.
8. +(+) T lymphocytes. Int Immunol 2001 13 : 411 19.
9. + cytotoxic T lymphocytes is dependent on cellular activation and perforin-mediated killing. Eur J Immunol 2004 34 : 2459 70.
10. Krueger A, Fas SC, Baumann S, Krammer PH. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol Rev 2003 193 : 58 69.
11. Podack ER, Hengartner H, Lichtenheld MG. A central role of perforin in cytolysis? Annu Rev Immunol 1991 9 : 129 57.
12. Voskoboinik I, Smyth MJ, Trapani JA. Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol 2006 6 : 940 52.
13. Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol 2003 3 : 361 70.
14. Stinchcombe JC, Griffiths GM. Secretory mechanisms in cell-mediated cytotoxicity. Annu Rev Cell Dev Biol 2007 23 : 495 517.
15. Cullen SP, Martin SJ. Mechanisms of granule-dependent killing. Cell Death Differ 2008 15 : 251 62.
16. 2+ action. Cell Immunol 1985 95 : 113 23.
17. Berke G, Rosen D. Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro. J Immunol 1988 141 : 1429 36.
18. Berke G. The CTL's kiss of death. Cell 1995 81 : 9 12.
19. Kägi D, Ledermann B, Bürki K et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994 369 : 31 7.
20. Walsh CM, Matloubian M, Liu CC et al. Immune function in mice lacking the perforin gene. Proc Natl Acad Sci USA 1994 91 : 10854 8.
21. 2+-independent T cell-mediated cytotoxicity. J Exp Med 1993 177 : 195 200.
22. Kägi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S, Hengartner H, Golstein P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994 265 : 528 30.
23. Nagata S, Golstein P. The Fas death factor. Science 1995 267 : 1449 56.
24. Lowin B, Mattman C, Hahne M, Tschopp J. Comparison of Fas(Apo-1\CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes. Int Immunol 1996 8 : 57 63.
25. He JS, Ostergaard HL. CTLs contain and use intracellular stores of FasL distinct from cytolytic granules. J Immunol 2007 179 : 2339 48.
26. Bossi G, Griffiths GM. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med 1999 5 : 90 6.
27. Walsh CM, Glass AA, Chiu V, Clark WR. The role of the Fas lytic pathway in a perforin-less CTL hybridoma. J Immunol 1994 153 : 2506 14.
28. + and TCR on 2C T cells. Mol Immunol 2002 39 : 687 95.
29. Berke G, Sullivan KA, Amos DB. Rejection of ascites tumor allografts. I. Isolation, characterization and in vitro reactivity of peritoneal lymphoid effector cells from BALB\c mice immune to EL4 leukosis. J Exp Med 1972 135 : 1334 50.
30. Li HH, Rosen D, Sondel P, Berke G. Immune privilege and FasL: two ways to inactivate effector cytotoxic T lymphocytes by FasL-expressing cells. Immunology 2002 105 : 267 77.
31. Berke G, Gabison D, Feldman M. The frequency of effector cells in populations containing cytotoxic T lymphocytes. Eur J Immunol 1975 5 : 813 18.
32. Li JH, Rosen D, Ronen D, Behrens CK, Krammer PH, Clark WR, Berke G. The regulation of CD95 ligand expression and function in CTL. J Immunol 1998 161 : 3943 9.
33. Zagury D, Bernard J, Thierness N, Feldman M, Berke G. Isolation and characterization of individual functionally reactive cytotoxic T lymphocytes. Conjugation, killing and recycling at the single cell level. Eur J Immunol 1975 5 : 818 22.
34. + T cell function by the transcription factor Eomesodermin. Science 2003 302 : 1041 3.
35. + T cell fate coupled by T-bet and eomesodermin. Nat Immunol 2006 12 : 1236 44.
36. Clark WR. An antigen-specific component of lectin-mediated cytotoxicity. Cell Immunol 1975 17 : 505 16.
37. Tsotsiashvilli M, Levi R, Arnon R, Berke G. Activation of influenza-specific memory cytotoxic T lymphocytes by Concanavalin A stimulation. Immunol Lett 1998 60 : 89 95.
38. Berke G. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu Rev Immunol 1994 12 : 735 73.
39. Berke G, Sullivan KA, Amos DB. Rejection of ascites tumor allograft. II. A pathway for cell-mediated tumor destruction in vitro by peritoneal exudate lymphoid cells. J Exp Med 1972 136 : 1594 604.
40. Berke G, Sullivan KA, Amos DB. Tumor immunity in vitro: destruction of a mouse ascites tumor through a cycling pathway. Science 1972 177 : 433 4.
41. Berke G, Amos DB. Cytotoxic lymphocytes in the absence of detectable antibody. Nature New Biol 1973 242 : 237 9.
42. Todd RF, Stulting RD, Berke G. Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cells. Cancer Res 1973 33 : 3203 8.
43. Berke G, Rosen D, Ronen D. Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes. Immunology 1993 78 : 105 12.
44. Schick B, Berke G. Competitive inhibition of cytotoxic T lymphocyte-target cell conjugation. A direct evaluation of membrane antigens involved in cell-mediated immunity. Transplantation. 1979 27 : 365 8.
45. Peshes-Yaloz N, Rosen D, Sondel PM, Krammer PH, Berke G. Up-regulation of Fas (CD95) expression in tumour cells in vivo. Immunology 2007 120 : 502 11.
46. Berke G, Rosen D. Are lytic granules and perforin 1 involved in lysis induced by in vivo-primed peritoneal exudate cytolytic T lymphocytes? Transplant Proc 1972 19 : 412 16.
47. Dennert G, Anderson CG, Prochazka G. High activity of N-alpha-benzyloxycarbonyl-l-lysine thiobenzyl ester serine esterase and cytolytic perforin in cloned cell lines is not demonstrable in in-vivo-induced cytotoxic effector cells. Proc Natl Acad Sci USA 1987 84 : 5004 8.
48. Garner R, Helgason CD, Atkinson EA et al. Characterization of a granule-independent lytic mechanism used by CTL hybridomas. J Immunol 1994 153 : 5413 22.
49. Nagler-Anderson C, Lichtenheld M, Eisen HN, Podack ER. Perforin mRNA in primary peritoneal exudate cytotoxic T ymphocytes. J Immunol 1989 143 : 3440 3.
50. +(+) T cells during primary activation. Int Immunol 2002 14 : 605 13.
51. Lehmann C, Zeis M, Schmitz N, Uharek L. Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells. Blood 2000 96 : 594 600.
52. + T cell lysis by preventing the cleavage of Bid by granzyme-B. Cell Death Differ 2003 10 : 1320 8.
53. Curtin JF, Cotter TG. Live and let die: regulatory mechanisms in Fas-mediated apoptosis. Cell Signal 2003 15 : 983 92.
54. Bidère N, Su HC, Lenardo MJ. Genetic disorders of programmed cell death in the immune system. Annu Rev Immunol 2006 24 : 321 52.
55. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004 22 : 745 63.
56. + T cells emerge at different stages of an in vivo immune response. J Immunol 1995 155 : 3443 52.
57. Chang JT, Palanivel VR, Kinjyo I et al. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 2007 315 : 1687 91.
58. Renno T, Attinger A, Locatelli S, Bakker T, Vacheron S, MacDonald HR. Cutting edge: apoptosis of superantigen-activated T cells occurs preferentially after a discrete number of cell divisions in vivo. J Immunol 1999 162 : 6312 15.